Lewis H. Titterton Jr., Director at Anixa Biosciences Inc (ANIX), bought 6,000 shares at $3.08 ($18K) on 2022-01-10, disclosed to the SEC on 2022-01-11.
Open-market purchase of $18k ANIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ANIX | BUY | 2026-07-20 | $42K | — | Filing → |
| ANIX | BUY | 2026-07-16 | $9K | — | Filing → |
| ANIX | BUY | 2026-06-17 | $7K | — | Filing → |